|
1
|
American Cancer Society: Cancer Facts and
Figures 2014. Atlanta, GA: American Cancer Society; 2014
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuphal S and Bosserhoff A: Recent progress
in understanding the pathology of malignant melanoma. J Pathol.
219:400–409. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flaherty KT, Lee SJ, Zhao F, Schuchter LM,
Flaherty L, Kefford R, Atkins MB, Leming P and Kirkwood JM: Phase
III trial of carboplatin and paclitaxel with or without sorafenib
in metastatic melanoma. J Clin Oncol. 31:373–379. 2013. View Article : Google Scholar
|
|
5
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schmalhofer O, Brabletz S and Brabletz T:
E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 28:151–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sullivan RJ and Flaherty KT: Resistance to
BRAF-targeted therapy in melanoma. Eur J Cancer. 49:1297–1304.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sinnberg T, Menzel M, Kaesler S,
Biedermann T, Sauer B, Nahnsen S, Schwarz M, Garbe C and Schittek
B: Suppression of casein kinase 1alpha in melanoma cells induces a
switch in beta-catenin signaling to promote metastasis. Cancer Res.
70:6999–7009. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lucero OM, Dawson DW, Moon RT and Chien
AJ: A re-evaluation of the 'oncogenic' nature of Wnt/β-catenin
signaling in melanoma and other cancers. Curr Oncol Rep.
12:314–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jones V and Katiyar SK: Emerging
phytochemicals for prevention of melanoma invasion. Cancer Lett.
335:251–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Lin Y, Liu H and Li J: Inhibition of
invasion and up-regulation of E-cadherin expression in human
malignant melanoma cell line A375 by
(−)-epigallocatechin-3-gallate. J Huazhong Univ Sci Technol Med
Sci. 28:356–359. 2008. View Article : Google Scholar
|
|
15
|
Vaid M, Prasad R, Sun Q and Katiyar SK:
Silymarin targets β-catenin signaling in blocking
migration/invasion of human melanoma cells. PLoS One. 6:e230002011.
View Article : Google Scholar
|
|
16
|
Serini S, Fasano E, Celleno L, Cittadini A
and Calviello G: Potential of long-chain n-3 polyunsaturated fatty
acids in melanoma prevention. Nutr Rev. 72:255–266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Algamas-Dimantov A, Yehuda-Shnaidman E,
Hertz R, Peri I, Bar-Tana J and Schwartz B: Prevention of
diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty
acids and (n-3) PUFA mimetic. Oncotarget. 5:9851–9863. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Denkins Y, Kempf D, Ferniz M, Nileshwar S
and Marchetti D: Role of omega-3 polyunsaturated fatty acids on
cyclooxygenase-2 metabolism in brain-metastatic melanoma. J Lipid
Res. 46:1278–1284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miller AB and Gaudette LA: Cancers of
skin, bone, connective tissues, brain, eye, thyroid and other
specified and unspecified sites in Inuit. Acta Oncol. 35:607–616.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bain C, Green A, Siskind V, Alexander J
and Harvey P: Diet and melanoma. An exploratory case-control study.
Ann Epidemiol. 3:235–238. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallagher RP, Elwood JM and Hill GB: Risk
factors for cutaneous malignant melanoma: The Western Canada
Melanoma Study. Cancer Res. 102:38–55. 1986.
|
|
22
|
Osterlind A, Tucker MA, Stone BJ and
Jensen OM: The Danish case-control study of cutaneous malignant
melanoma. IV. No association with nutritional factors, alcohol,
smoking or hair dyes. Int J Cancer. 42:825–828. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kirkpatrick CS, White E and Lee JA:
Case-control study of malignant melanoma in Washington State. II.
Diet, alcohol, and obesity. Am J Epidemiol. 139:869–880.
1994.PubMed/NCBI
|
|
24
|
Salem ML, Kishihara K, Abe K, Matsuzaki G
and Nomoto K: N-3 polyunsaturated fatty acids accentuate B16
melanoma growth and metastasis through suppression of tumoricidal
function of T cells and macrophages. Anticancer Res. 20:3195–3203.
2000.PubMed/NCBI
|
|
25
|
Demchenko DV, Pozharitskaya ON, Shikov AN
and Makarov VG: Validated HPTLC Method for Quantification of
Vitamin D-3 in Fish Oil. Journal of Planar Chromatography.
24:487–490. 2011. View Article : Google Scholar
|
|
26
|
Kang JX, Wang J, Wu L and Kang ZB:
Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids. Nature.
427:5042004. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia S, Lu Y, Wang J, He C, Hong S, Serhan
CN and Kang JX: Melanoma growth is reduced in fat-1 transgenic
mice: Impact of omega-6/omega-3 essential fatty acids. Proc Natl
Acad Sci USA. 103:12499–12504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bellenger J, Bellenger S, Clément L,
Mandard S, Diot C, Poisson JP and Narce M: A new hypotensive
polyunsaturated fatty acid dietary combination regulates oleic acid
accumulation by suppression of stearoyl CoA desaturase 1 gene
expression in the SHR model of genetic hypertension. FASEB J.
18:773–775. 2004.PubMed/NCBI
|
|
29
|
Wang Y, Armando AM, Quehenberger O, Yan C
and Dennis EA: Comprehensive ultra-performance liquid
chromatographic separation and mass spectrometric analysis of
eicosanoid metabolites in human samples. J Chromatogr A.
1359:60–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serhan CN, Chiang N, Dalli J and Levy BD:
Lipid mediators in the resolution of inflammation. Cold Spring Harb
Perspect Biol. 7:a0163112014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin WL, Lai DY, Lee YJ, Chen NF and Tseng
TH: Antitumor progression potential of morusin suppressing STAT3
and NFκB in human hepatoma SK-Hep1 cells. Toxico Lett. 232:490–498.
2015. View Article : Google Scholar
|
|
33
|
Ge C, Yu M and Zhang C: G protein-coupled
receptor 30 mediates estrogen-induced proliferation of primordial
germ cells via EGFR/Akt/β-catenin signaling pathway. Endocrinology.
153:3504–3516. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Novak A and Dedhar S: Signaling through
beta-catenin and Lef/Tcf. Cell Mol Life Sci. 56:523–537. 1999.
View Article : Google Scholar
|
|
35
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fortes C, Mastroeni S, Melchi F, Pilla MA,
Antonelli G, Camaioni D, Alotto M and Pasquini P: A protective
effect of the Mediterranean diet for cutaneous melanoma. Int J
Epidemiol. 37:1018–1029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Algamas-Dimantov A, Yehuda-Shnaidman E,
Hertz R, Peri I, Bar-Tana J and Schwartz B: Prevention of
diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty
acids and (n-3) PUFA mimetic. Oncotarget. 5:9851–9863. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Algamas-Dimantov A, Davidovsky D, Ben-Ari
J, Kang JX, Peri I, Hertz R, Bar-Tana J and Schwartz B:
Amelioration of diabesity-induced colorectal ontogenesis by omega-3
fatty acids in mice. J Lipid Res. 53:1056–1070. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Simchuk EJ and Low DE: Direct esophageal
metastasis from a distant primary tumor is a submucosal process: A
review of six cases. Dis Esophagus. 14:247–250. 2001. View Article : Google Scholar
|
|
40
|
Galindo-Hernandez O, Serna-Marquez N,
Castillo-Sanchez R and Salazar EP: Extracellular vesicles from
MDA-MB-231 breast cancer cells stimulated with linoleic acid
promote an EMT-like process in MCF10A cells. Prostaglandins Leukot
Essent Fatty Acids. 91:299–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bollrath J and Greten FR: IKK/NF-kappaB
and STAT3 pathways: Central signalling hubs in
inflammation-mediated tumour promotion and metastasis. EMBO Rep.
10:1314–1319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Damsky WE, Curley DP, Santhanakrishnan M,
Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D,
Rimm DL, McMahon M and Bosenberg M: β-catenin signaling controls
metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell.
20:741–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Spranger S, Bao R and Gajewski TF:
Melanoma-intrinsic β-catenin signalling prevents anti-tumor
immunity. Nature. 523:231–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie
H, Lai L, Dai Y and Zhang J: Expression of the fat-1 gene
diminishes prostate cancer growth in vivo through enhancing
apoptosis and inhibiting GSK-3 beta phosphorylation. Mol Cancer
Ther. 7:3203–3211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Song KS, Jing K, Kim JS, Yun EJ, Shin S,
Seo KS, Park JH, Heo JY, Kang JX, Suh KS, et al:
Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell
growth in vitro and in vivo via downregulation of Wnt/Beta-catenin
signaling. Pancreatology. 11:574–584. 2011. View Article : Google Scholar
|
|
47
|
Castellone MD, Teramoto H, Williams BO,
Druey KM and Gutkind JS: Prostaglandin E2 promotes colon cancer
cell growth through a Gs-axin-beta-catenin signaling axis. Science.
310:15042005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Biondo PD, Brindley DN, Sawyer MB and
Field CJ: The potential for treatment with dietary long-chain
polyunsaturated n-3 fatty acids during chemotherapy. J Nutr
Biochem. 12:787–796. 2008. View Article : Google Scholar
|
|
49
|
Pai R, Nakamura T, Moon WS and Tarnawski
AS: Prostaglandins promote colon cancer cell invasion; signaling by
cross-talk between two distinct growth factor receptors. FASEB J.
17:1640–1647. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Calder PC: n-3 polyunsaturated fatty
acids, inflammation, and inflammatory diseases. Am J Clin Nutr.
83(6 Suppl): 1505S–1519S. 2006.PubMed/NCBI
|
|
51
|
Serhan CN: Pro-resolving lipid mediators
are leads for resolution physiology. Nature. 510:92–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lone AA, Ganai SA, Ahanger RA, Bhat HA,
Bhat TA and Wani IA: Free radicals and antioxidants: Myths, facts
and mysteries. African Journal of Pure and Applied Chemistry.
7:91–113. 2013. View Article : Google Scholar
|
|
53
|
Kim KY, Cho HJ, Yu SN, Kim SH, Yu HS, Park
YM, Mirkheshti N, Kim SY, Song CS, Chatterjee B and Ahn SC:
Interplay of reactive oxygen species, intracellular Ca2+ and
mitochondrial homeostasis in the apoptosis of prostate cancer cells
by deoxypodophyllotoxin. J Cell Biochem. 114:1124–1134. 2013.
View Article : Google Scholar
|
|
54
|
Azad MB, Chen Y and Gibson SB: Regulation
of autophagy by reactive oxygen species (ROS): Implications for
cancer progression and treatment. Antioxid Redox Signal.
11:777–790. 2009. View Article : Google Scholar
|
